(Q38570574)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26293566%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

title

Innate and adaptive immune responses in the CNS (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26293566%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26293566%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

Burkhard Becher

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26293566%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

author name string

Ari Waisman

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26293566%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

publication date

1 September 2015

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26293566%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26293566%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

volume

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26293566%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

issue

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26293566%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

page(s)

945-955

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26293566%20AND%20SRC:MED&resulttype=core&format=json

CONDITIONS DETERMINING THE TRANSPLANTABILITY OF TISSUES IN THE BRAIN.

22 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2815%2900141-6

7 January 2021

Dendritic cells permit immune invasion of the CNS in an animal model of multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2815%2900141-6

7 January 2021

Effector T cell interactions with meningeal vascular structures in nascent autoimmune CNS lesions

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2815%2900141-6

7 January 2021

Transfer of central nervous system autoantigens and presentation in secondary lymphoid organs

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2815%2900141-6

7 January 2021

Primary oligodendrocyte death does not elicit anti-CNS immunity

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2815%2900141-6

7 January 2021

Central nervous system immune surveillance: on natalizumab, dendritic cells, and dangerous immune privilege

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2815%2900141-6

7 January 2021

https://api.crossref.org/works/10.1016%2FS1474-4422%2815%2900141-6

1 reference

7 January 2021

The evolution of adaptive immunity in vertebrates

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2815%2900141-6

7 January 2021

Development, maintenance and disruption of the blood-brain barrier

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2815%2900141-6

7 January 2021

Tryps and trips: cell trafficking across the 100-year-old blood-brain barrier

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2815%2900141-6

7 January 2021

Glial influence on the blood brain barrier.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2815%2900141-6

7 January 2021

Developmental origins of astrocyte heterogeneity: the final frontier of CNS development

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2815%2900141-6

7 January 2021

Innate immune responses in central nervous system inflammation

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2815%2900141-6

7 January 2021

Fate mapping analysis reveals that adult microglia derive from primitive macrophages

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2815%2900141-6

7 January 2021

Bone marrow-derived microglia play a critical role in restricting senile plaque formation in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2815%2900141-6

7 January 2021

Microglia in the adult brain arise from Ly-6ChiCCR2+ monocytes only under defined host conditions

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2815%2900141-6

7 January 2021

Synaptic pruning by microglia is necessary for normal brain development

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2815%2900141-6

7 January 2021

Janus-faced microglia: beneficial and detrimental consequences of microglial phagocytosis.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2815%2900141-6

7 January 2021

Fate mapping reveals origins and dynamics of monocytes and tissue macrophages under homeostasis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2815%2900141-6

7 January 2021

Experimental autoimmune encephalomyelitis repressed by microglial paralysis.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2815%2900141-6

7 January 2021

Microglia: new roles for the synaptic stripper.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2815%2900141-6

7 January 2021

Neuroinflammation in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2815%2900141-6

7 January 2021

Parkinson's disease dementia: a neural networks perspective

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2815%2900141-6

7 January 2021

Inflammatory processes in amyotrophic lateral sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2815%2900141-6

7 January 2021

Regulation of microglial proliferation during chronic neurodegeneration

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2815%2900141-6

7 January 2021

HIV-associated neurocognitive disorder.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2815%2900141-6

7 January 2021

General aspects and neuropathology of X-linked adrenoleukodystrophy.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2815%2900141-6

7 January 2021

Neurologic manifestations of sarcoidosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2815%2900141-6

7 January 2021

Wild-type microglia arrest pathology in a mouse model of Rett syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2815%2900141-6

7 January 2021

Aicardi-Goutières syndrome: a model disease for systemic autoimmunity

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2815%2900141-6

7 January 2021

Gain-of-function mutations in IFIH1 cause a spectrum of human disease phenotypes associated with upregulated type I interferon signaling

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2815%2900141-6

7 January 2021

Autoimmune channelopathies in paraneoplastic neurological syndromes

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2815%2900141-6

7 January 2021

Role of the innate and adaptive immune responses in the course of multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2815%2900141-6

7 January 2021

Acute disseminated encephalomyelitis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2815%2900141-6

7 January 2021

Hypocretin (orexin) biology and the pathophysiology of narcolepsy with cataplexy

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2815%2900141-6

7 January 2021

Rasmussen's encephalitis: clinical features, pathobiology, and treatment advances.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2815%2900141-6

7 January 2021

Immunopathogenesis of paraneoplastic neurological syndromes associated with anti-Hu antibodies: A beneficial antitumor immune response going awry

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2815%2900141-6

7 January 2021

Tumor-specific killer cells in paraneoplastic cerebellar degeneration

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2815%2900141-6

7 January 2021

Second primary tumor in anti-Ma1/2-positive paraneoplastic limbic encephalitis.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2815%2900141-6

7 January 2021

Stiff-person syndrome: insights into a complex autoimmune disorder

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2815%2900141-6

7 January 2021

Immunopathology of autoantibody-associated encephalitides: clues for pathogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2815%2900141-6

7 January 2021

Expanding the clinical, radiological and neuropathological phenotype of chronic lymphocytic inflammation with pontine perivascular enhancement responsive to steroids (CLIPPERS).

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2815%2900141-6

7 January 2021

Cutting edge: neuronal recognition by CD8 T cells elicits central diabetes insipidus

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2815%2900141-6

7 January 2021

Neuromyelitis optica lesions may inform multiple sclerosis heterogeneity debate

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2815%2900141-6

7 January 2021

Neuropsychiatric systemic lupus erythematosus: pathogenesis and biomarkers

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2815%2900141-6

7 January 2021

Cellular and synaptic mechanisms of anti-NMDA receptor encephalitis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2815%2900141-6

7 January 2021

AMPA receptor antibodies in limbic encephalitis alter synaptic receptor location.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2815%2900141-6

7 January 2021

Investigation of LGI1 as the antigen in limbic encephalitis previously attributed to potassium channels: a case series

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2815%2900141-6

7 January 2021

Encephalitis and GABAB receptor antibodies: novel findings in a new case series of 20 patients

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2815%2900141-6

7 January 2021

Encephalitis with refractory seizures, status epilepticus, and antibodies to the GABAA receptor: a case series, characterisation of the antigen, and analysis of the effects of antibodies.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2815%2900141-6

7 January 2021

Progressive encephalomyelitis, rigidity, and myoclonus: a novel glycine receptor antibody

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2815%2900141-6

7 January 2021

Antibodies to Kv1 potassium channel-complex proteins leucine-rich, glioma inactivated 1 protein and contactin-associated protein-2 in limbic encephalitis, Morvan's syndrome and acquired neuromyotonia

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2815%2900141-6

7 January 2021

A novel non-rapid-eye movement and rapid-eye-movement parasomnia with sleep breathing disorder associated with antibodies to IgLON5: a case series, characterisation of the antigen, and post-mortem study

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2815%2900141-6

7 January 2021

Microglia actions in Alzheimer’s disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2815%2900141-6

7 January 2021

ALS: a disease of motor neurons and their nonneuronal neighbors

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2815%2900141-6

7 January 2021

Endogenous regulatory T lymphocytes ameliorate amyotrophic lateral sclerosis in mice and correlate with disease progression in patients with amyotrophic lateral sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2815%2900141-6

7 January 2021

Mechanisms of mutant SOD1 induced mitochondrial toxicity in amyotrophic lateral sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2815%2900141-6

7 January 2021

Blood-CNS Barrier Impairment in ALS patients versus an animal model

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2815%2900141-6

7 January 2021

Amyotrophic lateral sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2815%2900141-6

7 January 2021

Amyotrophic lateral sclerosis: Problems and prospects

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2815%2900141-6

7 January 2021

Microglial repopulation model reveals a robust homeostatic process for replacing CNS myeloid cells

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2815%2900141-6

7 January 2021

Modulating inflammatory monocytes with a unique microRNA gene signature ameliorates murine ALS.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2815%2900141-6

7 January 2021

Absence of tumor necrosis factor-alpha does not affect motor neuron disease caused by superoxide dismutase 1 mutations

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2815%2900141-6

7 January 2021

Mutant SOD1 in cell types other than motor neurons and oligodendrocytes accelerates onset of disease in ALS mice.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2815%2900141-6

7 January 2021

Neuroinflammation in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2815%2900141-6

7 January 2021

Microglial physiology: unique stimuli, specialized responses

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2815%2900141-6

7 January 2021

Neuroinflammation in Parkinson's disease: a target for neuroprotection?

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2815%2900141-6

7 January 2021

Aggregated alpha-synuclein activates microglia: a process leading to disease progression in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2815%2900141-6

7 January 2021

Glial innate immunity generated by non-aggregated alpha-synuclein in mouse: differences between wild-type and Parkinson's disease-linked mutants

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2815%2900141-6

7 January 2021

What is microglia neurotoxicity (Not)?

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2815%2900141-6

7 January 2021

Pathogenesis of the immune reconstitution inflammatory syndrome affecting the central nervous system in patients infected with HIV.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2815%2900141-6

7 January 2021

In situ evidence of JC virus control by CD8+ T cells in PML-IRIS during HIV infection

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2815%2900141-6

7 January 2021

https://api.crossref.org/works/10.1016%2FS1474-4422%2815%2900141-6

1 reference

7 January 2021

Immunology of relapse and remission in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2815%2900141-6

7 January 2021

Neurons as targets for T cells in the nervous system.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2815%2900141-6

7 January 2021

Onconeural antibodies in sera from patients with various types of tumours.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2815%2900141-6

7 January 2021

Demonstration of anti-HuD specific oligoclonal bands in the cerebrospinal fluid from patients with paraneoplastic neurological syndromes. Qualitative evidence of anti-HuD specific IgG-synthesis in the central nervous system

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2815%2900141-6

7 January 2021

Ganglionitis in paraneoplastic subacute sensory neuronopathy: a morphologic study

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2815%2900141-6

7 January 2021

Differential roles of microglia and monocytes in the inflamed central nervous system

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2815%2900141-6

7 January 2021

Cell-mediated autoimmunity in paraneoplastic neurological syndromes with anti-Hu antibodies.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2815%2900141-6

7 January 2021

Neutrophil protease inhibition reduces neuromyelitis optica-immunoglobulin G-induced damage in mouse brain

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2815%2900141-6

7 January 2021

Presence of six different lesion types suggests diverse mechanisms of tissue injury in neuromyelitis optica

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2815%2900141-6

7 January 2021

A role for humoral mechanisms in the pathogenesis of Devic's neuromyelitis optica

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2815%2900141-6

7 January 2021

IgG marker of optic-spinal multiple sclerosis binds to the aquaporin-4 water channel

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2815%2900141-6

7 January 2021

Aquaporin water channels in the nervous system.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2815%2900141-6

7 January 2021

Intrathecal pathogenic anti-aquaporin-4 antibodies in early neuromyelitis optica

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2815%2900141-6

7 January 2021

Interleukin 6 signaling promotes anti-aquaporin 4 autoantibody production from plasmablasts in neuromyelitis optica.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2815%2900141-6

7 January 2021

Neuromyelitis optica: pathogenicity of patient immunoglobulin in vivo.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2815%2900141-6

7 January 2021

Intra-cerebral injection of neuromyelitis optica immunoglobulin G and human complement produces neuromyelitis optica lesions in mice.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2815%2900141-6

7 January 2021

Eosinophil pathogenicity mechanisms and therapeutics in neuromyelitis optica

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2815%2900141-6

7 January 2021

Molecular outcomes of neuromyelitis optica (NMO)-IgG binding to aquaporin-4 in astrocytes

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2815%2900141-6

7 January 2021

Oligodendrocytes are damaged by neuromyelitis optica immunoglobulin G via astrocyte injury.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2815%2900141-6

7 January 2021

Plasma exchange for severe attacks of CNS demyelination: predictors of response

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2815%2900141-6

7 January 2021

Cytotoxic effect of neuromyelitis optica antibody (NMO-IgG) to astrocytes: an in vitro study

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2815%2900141-6

7 January 2021

Increase of complement fragment C5a in cerebrospinal fluid during exacerbation of neuromyelitis optica

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2815%2900141-6

7 January 2021

Eculizumab in AQP4-IgG-positive relapsing neuromyelitis optica spectrum disorders: an open-label pilot study.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2815%2900141-6

7 January 2021

Neuromyelitis optica IgG and natural killer cells produce NMO lesions in mice without myelin loss

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2815%2900141-6

7 January 2021

Myelin-specific T cells also recognize neuronal autoantigen in a transgenic mouse model of multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2815%2900141-6

7 January 2021

Deconstructing the Peptide-MHC Specificity of T Cell Recognition

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2815%2900141-6

7 January 2021

Aquaporin 4-specific T cells in neuromyelitis optica exhibit a Th17 bias and recognize Clostridium ABC transporter

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2815%2900141-6

7 January 2021

Therapies for multiple sclerosis: translational achievements and outstanding needs

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2815%2900141-6

7 January 2021

α4-integrins control viral meningoencephalitis through differential recruitment of T helper cell subsets.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2815%2900141-6

7 January 2021

Maraviroc and JC virus-associated immune reconstitution inflammatory syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2815%2900141-6

7 January 2021

Therapeutic use of CCR5 antagonists is supported by strong expression of CCR5 on CD8+ T cells in progressive multifocal leukoencephalopathy-associated immune reconstitution inflammatory syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2815%2900141-6

7 January 2021

Street-experienced peripheral B cells traffic to the brain

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2815%2900141-6

7 January 2021

Daclizumab therapy for multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2815%2900141-6

7 January 2021

Inflammasomes in the CNS.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2815%2900141-6

7 January 2021

Inhibition of IL-12/IL-23 signaling reduces Alzheimer's disease-like pathology and cognitive decline.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2815%2900141-6

7 January 2021

Effect of high-dose simvastatin on brain atrophy and disability in secondary progressive multiple sclerosis (MS-STAT): a randomised, placebo-controlled, phase 2 trial

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2815%2900141-6

7 January 2021

The inverse of immunity

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2815%2900141-6

7 January 2021

Antigen-specific tolerance by autologous myelin peptide-coupled cells: a phase 1 trial in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2815%2900141-6

7 January 2021

Anti-aquaporin-4 monoclonal antibody blocker therapy for neuromyelitis optica.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2815%2900141-6

7 January 2021

Protective Autoimmunity: A Unifying Model for the Immune Network Involved in CNS Repair.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2815%2900141-6

7 January 2021

10.1016/S1474-4422(15)00141-6

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26293566%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

1 reference